S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LYEL Lyell Immunopharma Inc

0.4336

-0.0054 (-1.23%)

18 Apr 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Lyell Immunopharma (NASDAQ:LYEL)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more Lyell Immunopharma Charts.

Lyell Immunopharma (NASDAQ:LYEL)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more Lyell Immunopharma Charts.

Lyell Immunopharma Inc News

Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
Tuesday 15 April 2025 (5 days ago) • GlobeNewswire Inc.

Form PRE 14A - Other preliminary proxy statements
Friday 11 April 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 2 April 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 March 2025 (1 month ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 12 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 12 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 12 March 2025 (1 month ago) • Edgar (US Regulatory)

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024
Wednesday 12 March 2025 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (2 months ago) • Edgar (US Regulatory)

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
Wednesday 19 February 2025 (2 months ago) • GlobeNewswire Inc.

More Lyell Immunopharma Inc News Articles

The SherwinWilliams

Akamai Technologies

Warner Bros.Discovery

Johnson Controls

Waste Management

Banco Santander

Eurofarma Laboratorios ON

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions